Beili Gao

Toripalimab Plus Chemotherapy for Patients With Treatment-Naive Advanced Non–Small-Cell Lung Cancer: A Multicenter Randomized Phase III Trial (CHOICE-01)

Zhijie Wang, Lin Wu, Baolan Li et al. · Journal of Clinical Oncology · 2022 · 172 citations · Full text

Medicine, Oncology, Pharmacology +17

PIV and PILE Score at Baseline Predict Clinical Outcome of Anti-PD-1/PD-L1 Inhibitor Combined With Chemotherapy in Extensive-Stage Small Cell Lung Cancer Patients

Ran Zeng, Fang Liu, Fang Chen et al. · Frontiers in Immunology · 2021 · 72 citations · Full text

Medicine, Oncology, Pharmacology +17

Camrelizumab Plus Carboplatin and Pemetrexed as First-Line Treatment for Advanced Nonsquamous NSCLC: Extended Follow-Up of CameL Phase 3 Trial

Caicun Zhou, Gongyan Chen, Yunchao Huang et al. · Journal of Thoracic Oncology · 2023 · 69 citations · Full text

Medicine, Oncology, Pharmacology +11

Efficacy and Safety of Niraparib as Maintenance Treatment in Patients With Extensive-Stage SCLC After First-Line Chemotherapy: A Randomized, Double-Blind, Phase 3 Study

Xinghao Ai, Yueyin Pan, Jianhua Shi et al. · Journal of Thoracic Oncology · 2021 · 56 citations · Full text

Medicine, Oncology, Pharmacology +13

Lung Adenocarcinoma Harboring EGFR 19del/C797S/T790M Triple Mutations Responds to Brigatinib and Anti-EGFR Antibody Combination Therapy

Xiaofei Wang, Ling Zhou, Jiani C. Yin et al. · Journal of Thoracic Oncology · 2019 · 55 citations · Full text

Medicine, Genetics, Oncology +12